it's a positive for mine. it shows the commitment and incentives should drive our mutual interests. better to pay bonuses and get the results then flounder. market seems to like it.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%